A clinical trial of nivolumab in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (NCCH1510,OSCAR trial)
Phase of Trial: Phase II
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Alveolar soft part sarcoma; Clear cell sarcoma
- Focus Therapeutic Use
- Acronyms OSCAR
- 21 Nov 2016 Status changed from not yet recruiting to recruiting.
- 14 Nov 2016 Planned initiation date changed from 1 Nov 2016 to 26 Oct 2016.
- 19 Aug 2016 New trial record